DEX could attenuate AKI through KDM5A inhibition in sepsis, transcription and protein levels of genes such as TLR4, MYD88, MTA1, PTGS2, CASP3 associated with NF-κB signaling pathway were all compromising after treated with DEX. This evidence concerns the gene MYD88 and acute kidney injury.